NanoVibronix Announces Expanded Agreement With MDS Pharm Ltd. to Distribute UroShield in Israel

NanoVibronix Inc. has expanded its distribution agreement with MDS. Pharm Ltd., NanoVibronix’s current PainShield and WoundShield distributor in Israel, to market and distribute NanoVibronix’s UroShield in Israel. 
 
MDS Pharm Ltd. is a distributor of medical equipment for home-care and self-diagnostics. An integral element of the company’s mission is to provide customers with alternatives to medication and/or pain relief drugs. MDS has an established distribution network in Israel that includes health insurance providers, private pharmacies, health stores, beautician centers, private clinics, and leading health websites.

Dorit Grinberg, CEO of MDS Pharm Ltd., commented, “We are pleased to add an additional product line to our existing distribution agreement, strengthening the partnership between our companies. This enables MDS to take further steps towards our mission of providing customers with alternatives to medication, in this case potentially preventing the need for antibiotics that would traditionally be used to combat catheter associated urinary tract infections.”
 
UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI). UroShield is also intended to decrease pain and discomfort associated with urinary catheter use.
 
Brian Murphy, CEO of NanoVibronix, stated, “We are excited to have UroShield as an additional product for distribution in Israel, as catheter-associated UTIs accounted for approximately 50 percent of healthcare acquired bacteremia in long term care facilities. Israel is an attractive market for our products and MDS brings an established distribution network.”
 
NanoVibronix Inc. is a medical device company headquartered in Elmsford, N.Y., with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company’s technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including the disruption of biofilms and bacteria colonization, as well as providing pain relief. The devices can be administered at home, without the assistance of medical professionals. The company’s primary products include PainShield, UroShield and WoundShield.